Clovis Oncology (CLVS) rose in trading today due to positive news on one of its products. The company’s Rubraca product received a positive opinion from CHMP as a maintenance treatment for women with relapsed ovarian cancer. CLVS shares were up over +4% as of the time this content was created. Here is a recap of what happened.
Written By: Howard Greenberg As everyday traders put their trading plans into action for 2026, penny stocks might not be on many of their radars. It’s totally understandable why penny stocks may not appeal to the more calculated seasoned traders. Their reputations for susceptibility to manipulation, extreme volatility, and low liquidity make them way too […]
Read Article
A high-profile policy debate has re-entered the financial spotlight surrounding credit card interest rate caps. Last week, President Donald Trump called for a temporary national cap on credit card interest rates. He proposed a maximum annual rate of 10% over a one-year period, starting January 20, 2026. President Trump’s proposal would aim to combat the […]
Read Article
What is Prop Trading? Prop trading has exploded in popularity over the last five years. It’s transformed from a niche practice into a mainstream gateway for retail traders. There’s a lot of highly skilled traders out there who are sitting on the sidelines right now for two main reasons: Prop trading addresses both issues. In […]
Read Article
What if there was a “Wishlist Strategy” that can help trade options for your favorite stocks at a discount? On today’s MarketMinds episode, Scott Bauer revealed a way to consider putting a strategy just like this into action. He explains how it works, the ways this strategy can potentially avoid adding risk, and the huge […]
Read Article
On February 28, 2026, the energy world changed overnight when U.S. and Israeli forces launched coordinated strikes on Iran. Strait Of Hormuz (Circled Red) – Google Maps The conflict triggered an immediate crisis in the Strait of Hormuz — the narrow Persian Gulf chokepoint, where roughly 20% of the world’s daily crude oil flows. The […]
Read Article
Financial markets remain locked in a rolling correction, defined by a volatile reassessment of the “higher-for-longer” interest rate environment, as investors continue to navigate shifting geopolitical headlines, elevated bond yields, and mixed economic data. At the center of market unease remains the evolving situation in the Middle East. While tensions involving Iran continue to disrupt […]
Read ArticleWe choose to let our members and students speak for themselves. We do not actively solicit testimonials, no compensation has been paid for any testimonial, and testimonials are not necessarily representative of the experience of all students. All monetary claims made in testimonials that you see depicted in our marketing material have been verified by Prosper Trading Academy and attested to by the members that have given them. Verified testimonials encompass “experience” reviews that highlight the personal experiences of working with our team and “performance” testimonials where we verify trading success of students who have enrolled in our programs.Given the broad reach of the internet, testimonials and reviews of our programs that we have not been able to verify can be found on various websites across the internet which are beyond our editorial control. While we do very much enjoy hearing positive things from our students and it is critical to our mission that everyone is satisfied with their journey with Prosper, we encourage you to take both verified and unverified testimonials for what they are.